ENCLOSED

Poly Medicure Limited ,,IPOLYMED Regd. Office: 232 B, 3rd Floor. OkhlA lnC'lustriAI Estate, Phase-Ill, New Delhi· l 10 020 {INDIA) T: +91-l 1• 33550700, 47317000 E: info@polymedicure.com W: polymcdicure.com CIN: L 40300DL 1995PLC066923 Datt-: 07 August, 2026 Scrip Code: -531768 Scrip Code:- POLYMED The Manager, The Manager BSE Limited, National Stock Exchange of India Limited Departrnent of Corporate Services, Exchange Plaza, Plot No. C/1-Btock-G Phirozee Jeejeebhoy Towers, Bandra Kurla Complex, Bandra(E), Dalal Street, Mumbai-40CXX>1. Mumbai-400051. Subject. Outcome of the Board Meeting of the Company Ref: Compliance of Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 07th August, 2026, at Jaipur Marriott Hotel , Ashram Marg, Near Jawahar Circle, Rajasthan, Jaipur-302015, India approved the following businesses: 1. Financial Results Unaudited Financial Results (Consolidate & Standalone) for the First quarter ended on 30th June 2026. A signed copy of the above Financial Results (Standalone & Consolidated) along with Auditors' Review Reports thereon is attached herewith as ''Annexure -A" 2 Grant of Stock Options Nomination & Remuneration Committee, held on today i.e. August 07, 2026 approved grant of 1,476 (One Thousand Four Hundred Seventy Six Only) Stock Options under the Poly Medicure Limited Employee Stock Option Scheme 2020, to eligible employees. The disclosure(s) as required under Regulation 30 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/ClR/P/0155 dated November 11, 2024 and December 31, 2024, for the above mentioned ESOP Grant is enclosed herewith as "Annexure - B". 3. Allotment of Stock Options Nomination & Remuneration Committee, held on today i.e. August 07, 2026 approved Allotment of 1,975 Equity Shares having face value of Rs. 5/ -each to its eligible employees of the Company who has exercised the option Under its Employee Stock Option Scheme, 2020. Plants: Plot No.104· 105 & 115-116· 1 l 7, Sector-59, HSIIOC Industrial Area, Ballabgarh, Faridabad -121004, Haryana (INDIA) Plot No. 33-34, Sector-68, IMT. Faridabad-121004, (Haryana) INOIA T: +91-129-4287000, 3355070 Scanned with OKEN Scanner Consequent to this allotment, the paid-up Equity Share Capital of the Company stands increased to Rs. 50,68,07,325 (consisting of 10, 13,61,465 equity shares of face value of Rs. 5 each) from Rs. 50,67,97,450 (consisting of 10, 13,59,490 equity shares of face value of Rs. 5 each). The details as required under Regulation 10(c) SEBI (Share Based Employee Benefits Sweat Equity) Regulations, 2021 is Enclosed as" Annexure •C" 4. Re-appointment of Cost Auditors Re-appointment of M/s Jai Prakash & Company as the Cost Auditors of the Company for the Financial Year 2026-27. The information in terms of Regulation 30 read with Schedule Ill - Para A of Part A of the Listing Regulations (as applicable) and SEBI Circular No. HO/ 49/14/14(7)2025-CFD POD2/l/3762/2026 dated January 30, 2026 is enclosed herewith as "Annexure - D". 5. Resignation of Deputy Company Secretary, KMP Mr. Ravi Prakash has tendered his resignation from the position of Deputy Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company to pursue an alternate career opportunities outside the Organization. He tendered his resignation vide letter dated 21 July 2026 and will be relieved from his responsibilities with effect from close of business hours on 10 August 2026. The information in terms of Regulation 30 read with Schedule Ill - Para A of Part A of the Listing Regulations (as applicable) and SEBI Circular No. HO/49/14/14(7)2025-CFD· POD2/l/3762/2026 dated January 30, 2026 is enclosed herewith as "Annexure-E" The Meeting was started at 01.15 P.M. and concluded on 2:20 P.M. Kindly take a note of the same for your further needful and oblige us. Thanking You, Yours Sincerely For Poly Medicure Limited Av inash Chandra Company Secretary M. No. A32270 Scanned with OKEN Scanner POLY MEDICURE LIMITED Regd. Office: 2328, 3rd floor, Okhla Industrial Estate Phase III, New Delhi -110 020 ·,>IPOLYMED Website: www.polymedlcure.com, E-mall: lnvestorc11re@polymedlcure.com, CIN: L40300DL1995PLC0669:z3 STATEMENT OF UNAUDITED STANDALONE AND CON SOU DATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 (~ in lacs except per share data) standalone Consolidated Standalooe Consolidated Quartet Ended Quarter Ended Year Ended Year Ended Particulars 30.06.2026 31.03.2026 30.06.2025 30.06.2026 31.03.2026 30.06.2025 31.03.2026 31.03.2026 (Unaudited} (Audited) {Unaudited) (Unaudited) {Audited) (Unaudited) ( ALKfrt:.ed) (Audited) l Income a Rl!\lenuc from operations 43,109.95 44,301.49 38,404.67 52,537.55 53,451.11 40,321.07 1,66,246.18 1,87,525.92 b Ottler income 7,864.96 1,512.19 4,109.55 3,340.90 1,715.65 4,169.09 11,991.77 12,008.22 Total income (A) 45,974.91 45,813.68 42,514.22 55,878.45 55,226.79 4"4,490.16 1,78,238.25 1,99,534.14 2 Expense,s a Cost of matt'O<IIS consuned 15,274.60 13,696.45 12,874.86 18,387.50 15,507.80 14,107.35 53,885.50 59,938.70 b Purrnases of stock-in-trade 177.12 136.08 85.85 267.46 138.42 85.85 503.71 506.05 C Q\anges in inventones of finished goods, wort-in-progress and stock-in-trade (3,172.15) 953.25 (755.28) (4,680.08} 2,169.97 (1,470.17) {1,339.64) (763.63) d Employee benefits e,c:pense 8,890.80 7,810.19 6,921.40 12,690.29 12,614.10 7,439.74 31,314.62 40,225-59 e Research and development expenses - 788.01 766.14 726.30 789,11 674.29 728.45 2,980.30 2,987.59 f Finance cost 438.46 389.20 281.38 650.14 640.86 295.01 1,343.32 1,829.07 9 Depreciation and amortisation expense 2,647.00 2,550.70 2,295.49 3,625.28 3,823.20 2,337.02 9,789.82 11,551.66 h Othef expenses 9,067.13 8,831.05 8,377.81 12,573.51 11,306.83 8,804.71 34,291.11 40,399.97 Total expen.ses (B) 34,110.97 35,133.06 30,807.81 44,303.21 46,875.47 32,327.96 1,32,768.74 1,56,675.00 3 Profit before share of profit of associate, exceptional Item and tax (A-8) 11,863.94 10,680.62 11,706.41 11,575.24 8,351.32 12,162.20 45,469.Sl 42,859.14 4 Share ~ Profit of an associate - - - 155.33 170.90 132.43 - 568.37 Pn:,fit befure eroeptional item and tn 11,863.94 10,680.62 11,706.41 11,730.57 8,522.22 12,294.63 45,469.51 43,427.51 s Exceptional item Impact of labour Codes - - - 680.40 680.40 6 Profit before tax 11,863.94 10,680.62 11,70&.41 11.no.57 8,522.22 12,294.63 44,789.11 42,747.11 7 Tax expense a Current tax 2,506.74 2,32J.31 2,130.98 2,816.11 2,524.29 2,206.81 9,657.70 10,115.84 b Deferred tax 543.91 275.29 782.54 386.07 (526.02) 779.53 1,502.75 528.11 C Earlier year ta.ices 0.96 19.85 - 0.96 19.8S - 30.17 30.17 Total tax expense 3,051.61 2,618.45 2,913.52 3,203.14 2,018.12 2,986.34 11,190.62 10,674.12 Prvfttaftet'tax 8,812.33 8,062.17 8,792.89 8,527.43 6,504.10 9,308.29 33,598.49 32,072.99 9 Other comprehensive income Items that will not be reclassified to profit Of' loss : Remeasurements of defined benefit obligations (90.94) 83.97 (117.32) (90.94) 83.97 {117.32) 30.23 30.23 Tax impacts on abolle 22.89 (21.14) 29.53 22.89 (21.14) 29.53 (7.61) (7.61) Items that will be recl~fied to profit Of" loss in subsequent period: Exchange differences on translation ol financial statements ol roreign Subsidiaries - - - 63.73 2,426.97 19.07 - 4,6?5.97 Tax impacts on above - Total other comprehensive IIIC'Olne (68.05) 62.83 (87.79) (4.32) 2,489.80 (68.n) 22.62 4,648.59 Total comprehensive Income (a,mprislng profit after tax and other 10 1,744.28 8,125.00 8,705.10 8,523.11 8,993.90 9,239.57 33,621.11 36,721.58 com Income •fter tad 11 Net prvfit attributable to: E Nq ou ni -ty oh no trld oe llir ns r : i/ th lee p "a ~r ent ~.:~. ,.. .,.,.,.....". ._ ,. ~ ri, , 0...... . ~.. -- -- 8,60 (72 5. .5 02 6,6 (12 29 5. .1 09 9,308. -29 - -- 32,2 (11 43 [Showing first 8,000 characters — download PDF for full document]